JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.

Other languages Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Equities

688076

CNE1000051X5

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
56.89 ^CNY	+0.16%		+0.57%	+26.56%

May. 21	Certain A Shares of Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-MAY-2024.	CI
Apr. 22	Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Certain A Shares of Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-MAY-2024.	May. 20
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 22
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23
Sinopep-Allsino Biopharmaceutical's Raw Drug Material Gets OK to Submit Drug Application to US FDA; Shares Up 4%	Dec. 19
Sinopep-Allsino Biopharmaceutical Gets Nod to Issue Convertible Bonds	Nov. 17
Sinopep-Allsino’s Hypertension Drug Shortlisted for China’s Drug Procurement Program	Nov. 08
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-20
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(XSSC:688076) added to S&P Global BMI Index	23-09-18
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28
Jiande Xinglian Enterprise Management Co., Ltd. entered into an agreement to acquire 4.84% in Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. from Jiande Wuxing Biological Technology Co., Ltd. for CNY 369 million.	23-06-07
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-21
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 300 million in funding	23-04-20
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-18
Sinopep-Allsino Biopharma Unit to Buy 9% Stake in Biotech Firm	22-09-28
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29
Zhejiang Zhongcheng Pharmaceutical Co., Ltd. agreed to acquire 45% stake in Hangzhou Xinbosi Biopharmaceutical Co., Ltd. from Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. for CNY 13.5 million.	22-06-29
Certain A Shares of Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-MAY-2022.	22-05-20
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(SHSE:688076) added to Shanghai Stock Exchange Composite Index	22-05-20
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(SHSE:688076) added to Shanghai Stock Exchange A Share Index	22-05-20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Equities

688076

CNE1000051X5

Other languages

Filters